Take into the conversation
Questions to ask
- Does this source support the specific claim?
- Is it a product record, a study, or guidance?
- Does the evidence concern adults and this exact medicine?
- When was the status last checked?
The notes behind the questions
What the answer rests on
Product records answer the approval question
FDA means Food and Drug Administration.
FDA records checked on 28 September 2026 show the former approved sermorelin (Geref) products are no longer sold.
They show no FDA-approved sermorelin product currently on sale in the US.
The Federal Register is where the government publishes official notices; it records the end of those approvals.
It also records FDA's later finding that the old products had not been taken off sale for safety or effectiveness problems.
Studies answer narrower questions
The adult studies cited here were small and brief; some tested a closely related medicine with a small chemical change, rather than sermorelin itself.
The study behind the former growth treatment tested children who lacked growth hormone, the body's growth signal.
There was no separate group on a dummy treatment or another medicine to compare growth with.
Without that comparison, this study alone cannot tell us how much of the growth was due to the medicine.
Guidance helps frame the visit
Advice for medical boards says online care must be as thorough as care in a room; the state writes the prescribing rules that must be followed.
As of 26 September 2026, states differ on how someone may first review a patient's health and decide about treatment online.
Keep in your notes
Use the linked public records when checking a name or status. Ask whoever is treating you to walk you through any paper cited in support of your plan.